Skip to main content Skip to footer menu

Clifford Chance

Tagged: 'M&A corporate'

Results 1-10 of 1739

Clifford Chance advises the underwriters on IPO of Probiodrug AG

29 October 2014


The international law firm Clifford Chance has advised the underwriting banks led by Kempen & Co on the successful IPO of Probiodrug AG. Probiodrug AG with its registered office in Halle, Germany, is a biopharmaceutical company dedicated to the research and...

Clifford Chance sur l'accord d'exclusivité de LDC et Sofiprotéol

27 October 2014


Deux des principaux acteurs de l’agro-alimentaire français, Sofiprotéol et LDC, ont indiqué entrer en négociations exclusives pour la mise en œuvre d’un projet d’alliance ayant pour objet le développement d’une filière française de volaille performante à l’ambition...

Dawn raids: “being prepared” is the name of the game

24 October 2014


This article first appeared in the French daily financial newspaper ‘Les Echos’ on September 2, 2014 based on an interview with Clifford Chance partner Thomas Baudesson and counsel Charles-Henri Boeringer. Thomas and Charles-Henri, together with Karine...

Actualités M&A - Droit Boursier Septembre 2014

23 October 2014


This newsletter deals with the main regulatory and case law issues that are of interest over the relevant period. Les actualités M&A - Droit Boursier couvrent les développements en matière de droit des sociétés et droit boursier...

Shareholder Rights Directive II – is it on your radar?

22 October 2014


Earlier this year the Commission published a proposal to amend the 2007 Shareholder Rights Directive (the Directive). Both the original Directive and its proposed replacement are first and foremost instruments of company law, with improved corporate governance...